awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47826637-B8A90A95-267D-4C07-AB8C-8D6B7A9B4087
Q47826637-B8A90A95-267D-4C07-AB8C-8D6B7A9B4087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47826637-B8A90A95-267D-4C07-AB8C-8D6B7A9B4087
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
P2860
Q47826637-B8A90A95-267D-4C07-AB8C-8D6B7A9B4087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47826637-B8A90A95-267D-4C07-AB8C-8D6B7A9B4087
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
528970e43f667cbc246ab97148de40c4f27720d5
P2860
Pembrolizumab versus Ipilimumab in Advanced Melanoma